Neo-adjuvant chemo-(immuno-) therapy of advanced head and neck squamous cell carcinoma (HNSCC): A multicenter phase III randomized study comparing cisplatin (CDDP) + 5-FU with CDDP + 5-FU + recombinant interleukin 2 (rIL 2): Preliminary results
Keyword(s):
1992 ◽
Vol 102
(5)
◽
pp. 572-578
◽
1998 ◽
Vol 47
(3)
◽
pp. 149-156
◽
Keyword(s):
1991 ◽
Vol 10
(1)
◽
pp. 63-68
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 6066-6066
2011 ◽
Vol 18
(1)
◽
pp. 301-307
◽
Keyword(s):